Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-032440
Filing Date
2011-05-24
Accepted
2011-05-24 17:44:11
Documents
1
Period of Report
2011-05-20

Document Format Files

Seq Description Document Type Size
1 rrd313041.html 4  
1 rrd313041.xml 4 4146
  Complete submission text file 0001181431-11-032440.txt   5682
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address
Ozeroff Christopher David (Reporting) CIK: 0001454996 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 11868964